CLINICAL STUDY AGREEMENTClinical Study Agreement • November 22nd, 2022
Contract Type FiledNovember 22nd, 2022This Clinical Study Agreement (“Agreement”), effective as of //dd-MON-yyyy// (the “Effective Date”), is entered into by and among Medpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 (“Medpace”), represented by ; and Nemocnice Jihlava, a clinical research site with its principal office and place of business at Vrchlického 59, 586 33 Jihlava, Czech Republic, (“Institution”), represented by MUDr. Lukáš Velev, director, and , with his/her principal office and place of business at (“Principal Investigator”). Medpace, Institution and Principal Investigator are sometimes collectively referred to herein each as a “Party” or collectively as as the “Parties”.